Skip Navigation

Informed Flash

URGENT Announcing New Claims Clearinghouse

With the recent cyberattack at Change Healthcare, we’ve been working diligently to get another option in place for providers to submit claims.  We are glad to announce that we can now accept claims through Availity.  The new clearinghouse just became active late yesterday afternoon.

View Full Post

URGENT FLASH: Change Healthcare Network Interruption

As you may know, Optum-Change Healthcare experienced a network interruption related to a cybersecurity issue that began February 21, 2024. Health AllianceTM has partnered with Optum-Change Healthcare for inbound claims, eligibility and claims payments. These areas may be impacted by the incident.

View Full Post

FLASH: Health Alliance Prior Authorization Changes for 2024

Each year, Health AllianceTM performs a comprehensive review and analysis around services needing prior authorization. In our last review cycle, we removed prior authorization around ultrasound, oxygen therapy, non-urgent ground ambulance and select DME items.

View Full Post

FLASH: OSF Leaving Triple Option Plans

Recently, the contract between OSF HealthCare and Health Alliance™ came up for review between the two organizations. Health Alliance strives to offer a competitive product in the market with a tiered structure where there is reduced cost-sharing for patients when they see a Tier 1 provider. As such, there are certain contract terms that must be met to keep the product competitive in the market.

View Full Post

FLASH: New Low-Cost Options for Autoimmune Disorders

A few months ago, we added a new adalimumab product, Amjevita, to the Health AllianceTM commercial formulary with prior authorization. In addition to Amjevita, Health Alliance will now be adding two new biosimilar adalimumab products, Hadlima and Adalimumab-adaz. All three biosimilars will be covered across all formularies, including Medicare, in parity with Humira. Health Alliance continues to be committed to offering members and providers access to biosimilars as they become available.

View Full Post